In cisplatin-induced AKI mice, eudesmin treatment consistently promoted the expression of YY1 and inhibited KIM1 expression (Fig. 3f, g), reduced serum creatinine and urea nitrogen (BUN) levels and attenuated pathological injury (Fig. 3h–j). This evidence concerns the gene HAVCR1 and acute kidney injury.